Viatris: The Stock Is Up 55% in a Year. The Revenue Has Fallen Every Year Since 2021.
Before anything else The math, meaning what the filed numbers justify, shows a company whose top line has shrunk for...
Evidence Sheet: JPMorgan Chase & (JPM)
The standing BullScope yardsticks for JPMorgan Chase &, computed from official filings and refreshed with each new edition.
JPMorgan: Record Earnings, a 99th-Percentile Price Tag, and One Open Question
The heart of it The filed numbers show a bank earning more than it ever has, with net income of...
One Drug Carries the Weight: What Regeneron’s Filed Numbers Say About the Price
Dupixent's global net sales grew 38% in a single quarter. The stock is priced at a lower multiple than its...
Evidence Sheet: Mcdonalds (MCD)
The standing BullScope yardsticks for Mcdonalds, computed from official filings and refreshed with each new edition.
The Golden Arches at a Discount: What $271 Assumes McDonald’s Will Never Do Again
Six years ago, McDonald's was a pandemic-battered company selling coffee and fries to a world that had stopped commuting. Today...
The Bill Nobody Voted For
The filed numbers show that interest on the federal debt now costs more, on an annualized basis, than the entire...
Walmart’s operating income surges 28.8% as tariff refunds and eCommerce gains offset pricing pressure
Walmart reported second-quarter revenue of $187.9 billion, up 5.9% from the prior year (5.1% in constant currency), with operating income...
Evidence Sheet: Adobe (ADBE)
The standing BullScope yardsticks for Adobe, computed from official filings and refreshed with each new edition.
Abbott’s Split Screen: One Business Surging, One Shrinking, and a Stock Priced Somewhere in Between
Abbott spent the better part of a decade becoming something harder to categorize than a drug company. It makes the...
BullScope is an evidence-first investment research publication. Every note starts in the filings: what companies actually report, what the market assumes, and where the two disagree. We read the numbers so you can read the story. Not investment advice.